ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
LeonaBio Inc
6.92
+0.0600
0.87%
成交量:
4.27萬
成交額:
30.22萬
市值:
6,500.31萬
市盈率:
-0.30
高:
7.64
開:
6.75
低:
6.75
收:
6.86
52周最高:
14.21
52周最低:
3.54
股本:
939.35萬
流通股本:
473.04萬
量比:
0.53
換手率:
0.90%
股息:
- -
股息率:
- -
每股收益(TTM):
-23.0100
每股收益(LYR):
-24.7000
淨資產收益率:
-431.39%
總資產收益率:
-74.07%
市淨率:
1.93
市盈率(LYR):
-0.28
資料載入中...
總覽
公司
新聞
公告
LeonaBio完成拉索昔芬聯合阿貝西利III期ELAIN-3試驗第500例受試者入組——SEC文件披露
美股速递
·
08/27
LeonaBio Inc預計Lasofoxifene三期試驗患者招募將於2026年第四季度完成,關鍵數據將於2027年下半年公布
美股速递
·
03/27
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/LONA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LONA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":6.92,"timestamp":1789156800000,"preClose":6.86,"halted":0,"volume":42677,"delay":0,"changeRate":0.008746355685131138,"floatShares":4730400,"shares":9393514,"eps":-23.01,"marketStatus":"盤前交易","change":0.06,"latestTime":"09-14 05:41:17 EDT","open":6.75,"high":7.64,"low":6.75,"amount":302190.331667,"amplitude":0.129738,"askPrice":11,"askSize":100,"bidPrice":5.49,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-23.01,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":6.92,"postHourTrading":{"tag":"盘后","latestPrice":6.92,"preClose":6.92,"latestTime":"19:30 EDT","volume":37,"amount":254.4552,"timestamp":1789169406411,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5303559390264407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","floatShares":4730400,"roa":"-74.07%","roe":"-431.39%","lyrEps":-24.699999,"volumeRatio":0.5303559390264407,"shares":9393514,"dividePrice":0,"high":7.64,"amplitude":0.129738,"preClose":6.86,"low":6.75,"week52Low":3.538,"pbRate":"1.93","week52High":14.21,"institutionHeld":0,"latestPrice":6.92,"eps":-23.01,"divideRate":0,"volume":42677,"delay":0,"ttmEps":-23.01,"open":6.75,"prevYearClose":7.57,"prevWeekClose":6.92,"prevMonthClose":7.92,"prevQuarterClose":9.19,"fiveDayClose":7.7,"twentyDayClose":7.87,"sixtyDayClose":7.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LONA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"LONA","fiscalQuarterEnding":"2026/06","expectedEps":-1.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2026-05-07","symbol":"LONA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-1.73},{"market":"US","date":"2026-03-26","symbol":"LONA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"LONA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2025-09-18","symbol":"LONA","defaultRemindTime":1758202200000,"type":"split","dateTimestamp":1758168000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LONA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785470400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LONA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LONA","date":"2026-09-11","current":-0.300739,"percent":1,"low":-2.796591,"twenty":-1.185458,"median":-0.727664,"eighty":-0.557453,"high":-0.456913,"avg":-0.904525,"sd":0.473963,"marketCap":64632608},"quantilePoints":[{"date":"2026-01-16","current":-0.662315,"twenty":-0.686048,"median":-0.684271,"eighty":-0.675175,"marketCap":24984524},{"date":"2026-01-23","current":-1.56325,"twenty":-0.686675,"median":-0.673032,"eighty":-0.651338,"marketCap":58970481},{"date":"2026-01-30","current":-1.165659,"twenty":-1.344824,"median":-0.68793,"eighty":-0.65761,"marketCap":43972150},{"date":"2026-02-06","current":-1.185458,"twenty":-1.276038,"median":-1.158235,"eighty":-0.670888,"marketCap":44719023},{"date":"2026-02-13","current":-1.158234,"twenty":-1.22753,"median":-1.158234,"eighty":-0.684166,"marketCap":43692072},{"date":"2026-02-20","current":-1.368597,"twenty":-1.23248,"median":-1.158234,"eighty":-0.68542,"marketCap":51627598},{"date":"2026-02-27","current":-1.390871,"twenty":-1.374537,"median":-1.170609,"eighty":-0.765162,"marketCap":52467831},{"date":"2026-03-06","current":-1.329,"twenty":-1.392851,"median":-1.185458,"eighty":-1.076564,"marketCap":50133852},{"date":"2026-03-13","current":-1.856145,"twenty":-1.437398,"median":-1.225055,"eighty":-1.089928,"marketCap":70019347},{"date":"2026-03-20","current":-2.457536,"twenty":-1.517584,"median":-1.326525,"eighty":-1.109727,"marketCap":92705616},{"date":"2026-03-27","current":-2.395664,"twenty":-1.826942,"median":-1.36281,"eighty":-1.136951,"marketCap":90371637},{"date":"2026-04-02","current":-0.885775,"twenty":-1.710128,"median":-1.327762,"eighty":-1.074089,"marketCap":93545848},{"date":"2026-04-10","current":-0.848546,"twenty":-1.591335,"median":-1.23743,"eighty":-0.90876,"marketCap":89614123},{"date":"2026-04-17","current":-0.732027,"twenty":-1.56325,"median":-1.192883,"eighty":-0.852104,"marketCap":77308620},{"date":"2026-04-24","current":-0.766716,"twenty":-1.526988,"median":-1.173083,"eighty":-0.820084,"marketCap":80972090},{"date":"2026-05-01","current":-0.80941,"twenty":-1.479966,"median":-1.161946,"eighty":-0.806742,"marketCap":85480977},{"date":"2026-05-08","current":-0.877009,"twenty":-1.479232,"median":-1.15081,"eighty":-0.806742,"marketCap":92620048},{"date":"2026-05-15","current":-0.798435,"twenty":-1.470067,"median":-1.095125,"eighty":-0.784505,"marketCap":103328654},{"date":"2026-05-22","current":-0.730931,"twenty":-1.437893,"median":-1.038891,"eighty":-0.766716,"marketCap":94592685},{"date":"2026-05-29","current":-0.699719,"twenty":-1.435914,"median":-0.977518,"eighty":-0.742344,"marketCap":90553474},{"date":"2026-06-05","current":-0.624957,"twenty":-1.41958,"median":-0.881392,"eighty":-0.732312,"marketCap":80878155},{"date":"2026-06-12","current":-0.616247,"twenty":-1.397801,"median":-0.861888,"eighty":-0.723673,"marketCap":79750933},{"date":"2026-06-18","current":-0.597374,"twenty":-1.391861,"median":-0.852104,"eighty":-0.699139,"marketCap":77308620},{"date":"2026-06-26","current":-0.630764,"twenty":-1.383447,"median":-0.845878,"eighty":-0.684375,"marketCap":81629636},{"date":"2026-07-02","current":-0.608262,"twenty":-1.377507,"median":-0.836094,"eighty":-0.66996,"marketCap":78717647},{"date":"2026-07-10","current":-0.681573,"twenty":-1.373052,"median":-0.819033,"eighty":-0.654571,"marketCap":88205096},{"date":"2026-07-17","current":-0.566889,"twenty":-1.363967,"median":-0.812078,"eighty":-0.651338,"marketCap":73363344},{"date":"2026-07-24","current":-0.525515,"twenty":-1.345814,"median":-0.798435,"eighty":-0.635734,"marketCap":68009041},{"date":"2026-07-31","current":-0.529145,"twenty":-1.328505,"median":-0.788063,"eighty":-0.629457,"marketCap":68478717},{"date":"2026-08-07","current":-0.566889,"twenty":-1.323555,"median":-0.7765,"eighty":-0.623505,"marketCap":73363344},{"date":"2026-08-14","current":-0.571244,"twenty":-1.296827,"median":-0.749803,"eighty":-0.613488,"marketCap":73926955},{"date":"2026-08-21","current":-0.511329,"twenty":-1.23248,"median":-0.741811,"eighty":-0.606085,"marketCap":72330057},{"date":"2026-08-28","current":-0.525516,"twenty":-1.210206,"median":-0.735286,"eighty":-0.594326,"marketCap":74336921},{"date":"2026-09-04","current":-0.512861,"twenty":-1.197337,"median":-0.731479,"eighty":-0.571244,"marketCap":72546805},{"date":"2026-09-11","current":-0.456913,"twenty":-1.185458,"median":-0.727664,"eighty":-0.557453,"marketCap":64632608}],"updateTime":1789378877766},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LONA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103736186","title":"LeonaBio完成拉索昔芬聯合阿貝西利III期ELAIN-3試驗第500例受試者入組——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103736186","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103736186?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 04:40","pubTimestamp":1787776809,"startTime":"0","endTime":"0","summary":"LeonaBio宣布,其拉索昔芬联合阿贝西利方案的III期ELAIN-3临床试验已成功完成第500例受试者入组。这一里程碑式的进展已在最新提交给美国证券交易委员会(SEC)的文件中正式披露。\n值得关注的是,ELAIN-3试验旨在评估拉索昔芬与CDK4/6抑制剂阿贝西利联用的疗效与安全性。此次入组人数的突破,标志着该研究项目在推进过程中迈出了坚实的一步。通过SEC文件的公开信息,市场得以一窥这一关键节点的最新动态。\n业内观察人士认为,随着受试者招募工作的持续推进,该试验的数据积累正逐步走向成熟,未来有望为相关治疗领域提供更具说服力的循证依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LONA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124104746","title":"LeonaBio Inc預計Lasofoxifene三期試驗患者招募將於2026年第四季度完成,關鍵數據將於2027年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1124104746","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124104746?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 05:13","pubTimestamp":1774559590,"startTime":"0","endTime":"0","summary":"LeonaBio Inc宣布,其针对Lasofoxifene的三期临床试验预计将在2026年第四季度完成患者招募工作。该试验的关键数据结果计划于2027年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LONA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}